Analyst Ratings for 4D Pharma PLC (LBPS)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
6/27/2022 | Chardan Capital Markets | Globa Amusa | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.65 (1.65) |
0% | Details |
5/13/2021 | Ladenburg Thalmann | Michael Higgins | New Coverage | Buy (N/A) |
35.00 (N/A) |
10.55 (1.65) |
-84.36% | Details |